ARCIL IPO: The First Listed Bad-Loan Buyer, and a Timing Question

ARCIL is a different kind of IPO from the ones I have been writing about. It is not expensive. In fact it looks cheap. The company has spent more than two decades dealing with some of India's toughest bad-loan situations, and it is coming to market at a valuation that actually leaves room to think. The catches are a 100% offer for sale and a sharp jump in debt. Here is how I read it.

What ARCIL does

ARCIL buys bad loans. It was set up in 2002 as India's first asset reconstruction company, or ARC, and today it is the largest private ARC by assets under management, with about ₹20,150 crore of AUM as of March 2026. Over its life it has handled roughly ₹1.35 lakh crore of banking-system dues, with cumulative recoveries of about ₹31,915 crore by March 2026.

The model is simple to describe. Banks want stressed loans off their books. ARCIL buys those loans at a discount, then tries to recover more than it paid through settlements, restructuring, enforcement of security, IBC and NCLT processes, asset sales and collections. It usually parks the loans it buys into trusts, and each trust issues Security Receipts, or SRs. ARCIL earns management and trustee fees on the trusts it runs, plus investment income on the SRs it holds, which includes both real cash recoveries and changes in the estimated value of those SRs.

One shift is worth noting. ARCIL has been moving towards SME and retail stressed assets. These made up about 53% of its acquisitions in FY26, up from 19% in FY20, and retail alone is now about 24% of the portfolio, up from 6% in FY20. That matters, because it is where new stress in the system is actually building.

The IPO, and who is selling

The issue is ₹733 crore, and it is 100% an offer for sale. There is no fresh issue, so the company receives nothing. Every rupee goes to the shareholders who are selling. The price band is ₹132 to ₹139, the lot is 107 shares, the post-issue market cap is about ₹4,516 crore, and it lists on 17 September 2026 as India's first listed ARC.

The four sellers are worth looking at one by one, because the story is more nuanced than "the promoters are exiting."

Avenue and SBI are only partially trimming, and Avenue stays the dominant shareholder after the IPO. GIC-backed Lathe Investment is the one fully exiting its roughly 5% stake, and Federal Bank is selling only a small piece. So this is not a clean-out by the owners. It is a mix of partial monetisation and one financial investor heading for the door.

Financials

These are standalone numbers.

FY26 looked strong, with income up about 26% and profit up about 15%. ARCIL also reports a separate, lower consolidated profit (about ₹352 crore) because of how it has to account for the trusts it controls, so you will see the P/E quoted anywhere from about 11x to 13x depending on which basis a source uses.

Valuation

At ₹139, the market cap is about ₹4,516 crore, which is roughly 11x FY26 standalone profit and about 1.47x book value (net asset value is about ₹94.8 a share). There is no listed Indian ARC to compare it against, so there is no clean public benchmark. But on its own numbers, this is a reasonable price for a profitable business with a long track record. Next to the other IPOs open this week, the multiple is far more sober.

The debt jump, and the real question

The number I would investigate hardest is the debt. Borrowings went from ₹150 crore to ₹306 crore to ₹1,206 crore over three years, almost a fourfold jump in FY26 alone.

For an ARC, more debt is not automatically bad. ARCIL borrowed to buy more stressed assets. Its acquisitions rose to about ₹5,959 crore in FY26 from about ₹3,976 crore in FY25, and it put more of its own capital into these deals as the industry shifts towards buying loans for cash upfront rather than for SRs. CRISIL expects ARCIL to keep taking on debt to fund acquisitions.

That can be good leverage if the assets are recovered at attractive returns, and bad leverage if recovery takes longer than expected or the assets were bought too aggressively. One data point makes this worth watching. Even as acquisitions jumped, recoveries actually fell in FY26 to about ₹3,484 crore from ₹3,883 crore in FY25. So the real question is not "is ARCIL cheap." It is "did ARCIL deploy that extra roughly ₹900 crore of debt into assets that can generate good recoveries." That is what I would dig into before calling it a clear subscribe.

Why the timing could actually work for ARCIL

Here is the part I find genuinely interesting, and it cuts against the easy criticism that ARCs have run out of raw material. Yes, headline bank bad loans are at multi-decade lows. But look at how banks are behaving. Write-offs are rising, and banks are increasingly choosing to sell stressed loans to ARCs at a discount for quick relief rather than fight long, expensive recovery battles themselves. A fast, clean sale that takes a loan off the books is often more attractive to a bank than years of litigation, even at a lower price. That behaviour feeds ARCs like ARCIL.

Two more things point the same way. The RBI's move towards an expected-credit-loss framework should make banks recognise stress earlier, which could increase the flow of assets available to ARCs, and ARCIL itself expects non-NPA stressed assets to become a bigger opportunity. And the stress that is building is in retail and SME lending, exactly the segments ARCIL has been growing into. So while the old pool of large corporate bad loans is shrinking, the flow of discounted sales, earlier recognition and retail and SME stress could keep the pipeline fuller than the low headline NPA numbers suggest.

The risks that matter

• 100% offer for sale. The company gets no fresh capital, and the whole issue is existing owners selling.
• The fourfold jump in debt to ₹1,206 crore. Good leverage only if the bought assets recover well, and recoveries dipped in FY26.
• Ageing book. About 34.94% of AUM is more than eight years old, and older assets are harder to recover.
• Concentration. About 68.75% of AUM is corporate, and the top 10 corporate portfolios are about 22% of AUM.
• Earnings quality. A meaningful part of income comes from investment income, write-backs and fair-value movements, so the headline ₹408 crore profit is not as clean as it looks. CRISIL specifically notes the volatility built into the distressed-assets business.
• Regulatory watchpoints. ARCIL has received RBI observations on areas including KYC, due diligence, acquisition and resolution policies, statutory returns and internal controls. No penalty was imposed in the last three years, but it is worth keeping in view.

The reassuring counterweight: CRISIL rates ARCIL's long-term bank facilities AA-/Stable, citing comfortable capitalisation, its market position, and its track record of acquisitions and recoveries.

The GMP

The unofficial grey market premium is around ₹30, or about 21% over the ₹139 upper band. Early demand was subdued, with day-one subscription running well below full. As always, the grey market premium is an unofficial, moving indicator of short-term mood, and I would not build an investment case around it.

My verdict

I actually like ARCIL more than most of the other IPOs open this week, and the reason is the valuation. At about 11x earnings and 1.5x book, you are not paying an aggressive multiple for a business with a two-decade track record, strong profitability and a sizeable stressed-asset franchise. And the backdrop could be turning in its favour, as rising write-offs and banks preferring quick discounted sales push more loans towards ARCs.

But I would not call it a no-brainer. The fourfold jump in debt, the dip in recoveries, the ageing book and the fact that a good part of the profit is non-cash are all real, and this is a lumpy, cyclical business, not a steady compounder.

So where do I land? At ₹139, I would consider subscribing, but with a smaller allocation than I would give a high-quality growth business. The thesis is low valuation plus a strong franchise plus recovery upside, set against debt-funded growth, ageing assets and unpredictable recovery timelines. That is a genuinely interesting risk and reward, and a far more sober one than paying up for a hot, expensive listing.

One line to remember: ARCIL is not a flashy IPO, but at about 11x earnings, the price gives you enough room to investigate the story rather than pay for perfection.

Educational purposes only, not investment advice. DYOR.

Sources: ARCIL (Asset Reconstruction Company (India) Ltd) RHP and IPO disclosures (issue size, 100% OFS structure, selling shareholders, FY24 to FY26 financials, borrowings, AUM mix, RBI observations, risk factors); CRISIL rating rationale (AA-/Stable) and industry data; Financial Express, Groww, Anand Rathi and Moneycontrol reporting on the IPO, GMP and subscription; RBI and industry commentary on write-offs, the expected-credit-loss framework and stressed-asset flows (as of 9 to 10 September 2026). Standalone and consolidated profit differ, so the P/E depends on the basis used. Figures are approximate and as of the IPO. Verify live before acting.

Follow along: @tyrovirtuoso on X